[1] XU H X, WANG Y, ZHENG D D, et al. Differential expression of microRNAs in calcific aortic stenosis[J]. Clin Lab, 2017, 63(7):1163-1170. [2] XIAO X, ZHOU T, GUO S, et al. LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4[J]. Int J Cardiol, 2017, 15(9):404-412. [3] ZHANG Y, LIN X, ZHANG L, et al. MicroRNA-222 regulates the viability of fibroblasts in hypertrophic scars via matrix metalloproteinase 1[J]. Exp Ther Med, 2018, 15(2):1803-1808. [4] HADJI F, BOULANGER M C, GUAY S P, et al. Altered DNA methylation of long noncoding RNA H19 in calcific aortic valve disease promotes mineralization by silencing NOTCH1[J]. Circulation, 2016, 134(23):1848-1862. [5] YOSHIZUKA M, NAKASA T, KAWANISHI Y, et al. Inhibition of microRNA-222 expression accelerates bone healing with enhancement of osteogenesis, chondrogenesis and angiogenesis in a rat refractory fracture model[J]. J Orthop Sci, 2016, 21(6):852-858. [6] MELOCHE J, LAMPRON M C, NADEAU V, et al. Implication of inflammation and epigenetic readers in coronary artery remodeling in patients with pulmonary arterial hypertension[J]. Arterioscler Thromb Vasc Biol, 2017, 37(8):1513-1523. [7] WANG X, WANG H X, LI Y L, et al. MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis[J]. Hypertension, 2015, 66(4):776-785. [8] HAN Y, LIU Y H, YANG C K, et al. LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222/ING5 axis[J].Cell Mol Biol Lett, 2020, 17(3):25:21. |